MondayNov 03, 2008 3:57 am

Advanced Battery Technologies, Inc. (NASDAQ: ABAT)

Advanced Battery Technologies, Inc. (NASDAQ: ABAT), a developer, manufacturer and distributor of rechargeable Polymer Lithium-Ion (PLI) batteries, is focused on developing batteries that overcome many of the shortcomings of traditional rechargeable batteries by combining high-energy chemistry with state-of-the-art polymer technology. The company's products include rechargeable PLI batteries for electric automobiles, motorcycles, mine-use lamps, notebook computers, walkie-talkies and other electronic devices. For further information, visit the Company's web site at www.abat.com.cn.

Continue Reading

MondayNov 03, 2008 3:56 am

Adherex Technologies, Inc. (AMEX: ADH)

Adherex Technologies, Inc. (AMEX: ADH), a biopharmaceutical company, is focused on discovering and developing novel cancer therapeutics. They currently have a number of products in the clinical stage of development, including eniluracil, ADH-1 and sodium thiosulfate (STS). Adherex’s mission is to become a leading developer of innovative treatments that address important unmet medical needs in cancer. For further information, visit the Company's web site at www.adherex.com.

Continue Reading

MondayNov 03, 2008 3:54 am

Adanac Molybdenum Corporation (TSX: AUA CN)

Adanac Molybdenum Corporation (TSX: AUA CN) owns the Ruby Creek Molybdenum Project in Northern British Columbia. To date, the Company has advanced Ruby Creek through feasibility studies, a production decision and has ordered $137 million of long-lead equipment, completed permitting for construction, constructed a road to the site and secured US$80 million in bridge financing. This project has the potential of becoming the world’s first new large scale molybdenum open pit mine in more than 25 years. For further information, visit the Company's web site at www.adanacmoly.com.

Continue Reading

MondayNov 03, 2008 3:54 am

Action Energy Inc. (TSX: AEC CN)

Action Energy Inc. (TSX: AEC CN), an Alberta-based emerging oil and natural gas exploration and production company, has an asset base that includes a mix of light oil, conventional heavy oil and natural gas-producing properties in west central Alberta, Peace River Arch, east central Alberta and southwest and southeast Saskatchewan. The properties offer extensive opportunities to add reserves and production at low cost and low risk. For further information, visit the Company's web site at www.action-energy.com.

Continue Reading

MondayNov 03, 2008 3:53 am

Access Pharmaceuticals, Inc. (OTC BB: ACCP)

Access Pharmaceuticals, Inc. (OTC BB: ACCP), an emerging biopharmaceutical company, is committed to the development and commercialization of propriety products for the treatment and supportive care of cancer patients. Access' products currently include ProLindac(TM), the company’s lead oncology drug which is currently in Phase 2 clinical testing; and MuGard(TM), a viscous, mucoadhesive rinse for the management of patients with mucositis. For further information, visit the Company's web site at www.accesspharma.com.

Continue Reading

MondayNov 03, 2008 3:53 am

L & L International Holdings, Inc. (OTC BB: LLFH)

L & L International Holdings, Inc. (OTC BB: LLFH) is a US public traded company that serves as a bridge connecting coal (energy) business between the US and China. While capitalizing on this market, L & L is continuing to make profit in the marketplace and friends in the environment. L & L is acquiring additional coal mines, and in the process, doing their part to improve the quality of air. For further information, visit the company website at: www.lnlinternational.com.

Continue Reading

MondayNov 03, 2008 3:52 am

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI)

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) is focused on commercializing patent-protected disruptive healthcare technologies specifically designed to take leading roles for the treatment of a broad array of chronic, debilitating and life-threatening diseases including respiratory, autoimmune and cancer indications. The company anticipates building significant value for its shareholders while meeting its objectives. For further information, visit the Company's web site at www.accentia.net.

Continue Reading

SundayNov 02, 2008 9:10 am

Adherex Technologies, Inc. (AMEX: ADH)

Adherex Technologies, Inc. (AMEX: ADH), a biopharmaceutical company, is focused on discovering and developing novel cancer therapeutics. They currently have a number of products in the clinical stage of development, including eniluracil, ADH-1 and sodium thiosulfate (STS). Adherex’s mission is to become a leading developer of innovative treatments that address important unmet medical needs in cancer. For further information, visit the Company's web site at www.adherex.com.

Continue Reading

SundayNov 02, 2008 9:09 am

Access Pharmaceuticals, Inc. (OTC BB: ACCP)

Access Pharmaceuticals, Inc. (OTC BB: ACCP), an emerging biopharmaceutical company, is committed to the development and commercialization of propriety products for the treatment and supportive care of cancer patients. Access' products currently include ProLindac(TM), the company’s lead oncology drug which is currently in Phase 2 clinical testing; and MuGard(TM), a viscous, mucoadhesive rinse for the management of patients with mucositis. For further information, visit the Company's web site at www.accesspharma.com.

Continue Reading

SundayNov 02, 2008 9:09 am

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI)

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) is focused on commercializing patent-protected disruptive healthcare technologies specifically designed to take leading roles for the treatment of a broad array of chronic, debilitating and life-threatening diseases including respiratory, autoimmune and cancer indications. The company anticipates building significant value for its shareholders while meeting its objectives. For further information, visit the Company's web site at www.accentia.net.

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered